← Open Payments lookup

JOY BRIGHT-AGINDOTAN: Open Payments

NPI 1184004178 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$788 in 24 payments from 10 companies in 2025. Trend: 2023 $20 · 2024 $28 · 2025 $788

Food & beverage: $788
CompanyPaymentsAmount
Madrigal Pharmaceuticals2$161
Gilead Sciences, Inc.3$157
Janssen Biotech, Inc.5$113
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$92
Ipsen Biopharmaceuticals, Inc3$69
PFIZER INC.2$62
Lilly USA, LLC2$57
ABBVIE INC.1$29
Novo Nordisk Inc1$26
Janssen Scientific Affairs, LLC1$23

Products named: REZDIFFRA, TREMFYA, Livdelzi, XIFAXAN, IQIRVO, OMVOH, XELJANZ, LINZESS.

Industry payments across DC — which companies pay providers there.